The evidence reveals a "cloudy picture" of communication between hospitals, consultants, and GPs:

Evidence under reference 122086 illustrates the severe consequences when medication regimes—particularly for long-term metabolic or neurological conditions—are disrupted. A key issue identified is the between different brands of the same drug.

: Improving the "digital prescription" process so all parties—GP, consultant, and pharmacist—are synchronized.

: Patients often discover medication changes only upon receiving their "plastic boxes" of pills, rather than through prior consultation.

Beyond individual patient testimony, the broader inquiry (often associated with such evidence) explores the sustainability of community pharmacies.

: Mandatory consultation before changing a patient's medication brand, especially for time-critical drugs.